Health Insurance MarketplaceSM, 35530-35532 [2017-15960]
Download as PDF
35530
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755.
Please cite OMB Control No. 9000–
0024, Buy American, Trade Agreements,
and Duty-Free Entry in all
correspondence.
Dated: July 25, 2017.
Lorin S. Curit,
Director, Federal Acquisition Policy Division,
Office of Government-wide Acquisition
Policy, Office of Acquisition Policy, Office
of Government-wide Policy.
[FR Doc. 2017–16022 Filed 7–28–17; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10110]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
September 29, 2017.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
sradovich on DSKBCFCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:38 Jul 28, 2017
Jkt 241001
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development
Attention: Document Identifier/OMB
Control Number lllRoom C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
approval. To comply with this
requirement, CMS is publishing this
notice.
Contents
[FR Doc. 2017–16016 Filed 7–28–17; 8:45 am]
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
BILLING CODE 4120–01–P
CMS–10110 Manufacturer Submission
of Average Sales Prices (ASP) Data for
Medicare Part B Drugs
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection;
Title of Information Collection:
Manufacturer Submission of Average
Sales Prices (ASP) Data for Medicare
Part B Drugs; Use: In accordance with
Section 1847A of the Social Security
Act (the Act), Medicare Part B covered
drugs and biologicals not paid on a cost
or prospective payment basis are paid
based on the average sales price (ASP)
of the drug or biological, beginning in
Calendar Year (CY) 2005. The ASP data
reporting requirements are specified in
Section 1927 of the Act. The reported
ASP data are used to establish the
Medicare payment amounts. Form
Number: CMS–10110 (OMB control
number: 0938–0921); Frequency:
Quarterly; Affected Public: Business or
other For-profits; Number of
Respondents: 180; Total Annual
Responses: 720; Total Annual Hours:
9360. (For policy questions regarding
this collection contact Felicia Eggleston
at 410–786–9287.)
Dated: July 25, 2017.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7045–N]
Health Insurance MarketplaceSM,
Medicare, Medicaid, and Children’s
Health Insurance Programs;
Announcement of the Renewal of the
Charter for the Advisory Panel on
Outreach and Education (APOE)
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
renewal of the charter of the Advisory
Panel on Outreach and Education APOE
(the Panel) in accordance with the
Federal Advisory Committee Act. The
Panel advises and makes
recommendations to the Secretary of the
U.S. Department of Health and Human
Services (HHS) and the Administrator of
the Centers for Medicare & Medicaid
SUMMARY:
E:\FR\FM\31JYN1.SGM
31JYN1
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
sradovich on DSKBCFCHB2PROD with NOTICES
Services (CMS) on opportunities to
enhance the effectiveness of consumer
education strategies concerning the
Health Insurance MarketplaceSM,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP).
Additional information about the Panel
is available on the Internet at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html.
Press inquiries are handled through the
CMS Press Office at (202) 690–6145.
FOR FURTHER INFORMATION CONTACT:
Thomas Dudley, (410) 786–1442.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of Federal
Advisory Committee Act (FACA) (Pub.
L. 92–463), as amended (5 U.S.C.
appendix 2), which sets forth standards
for the formation and use of federal
advisory committees. The Panel is
authorized by section 1114(f) of the
Social Security Act (42 U.S.C. 1314(f))
and section 222 of the Public Health
Service Act (42 U.S.C. 217a).
On January 21, 1999, the Secretary of
the U.S. Department of Health and
Human Services (HHS) (the Secretary)
signed the charter establishing the
Citizen’s Advisory Panel on Medicare
Education 1 (the predecessor to the
APOE) to advise and make
recommendations to the Secretary and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare education programs, including
with respect to the Medicare+Choice
(M+C) program added by the Balanced
Budget Act of 1997 (Pub. L. 105–33).
(For more detailed information, see the
February 17, 1999 Federal Register (64
FR 7899)).
The Medicare Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program.
CMS has substantial responsibilities to
provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. Successful
MA program implementation required
CMS to consider views and policy input
from a variety of private sector
constituents and to develop a broad
range of public-private partnerships.
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014
17:38 Jul 28, 2017
Jkt 241001
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, CMS has substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available and to develop better
tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient
Protection and Affordable Care Act,
Public Law 111–148, and Health Care
and Education Reconciliation Act of
2010, Public Law 111–152) expanded
the availability of options for health care
coverage and enacted a number of
changes to Medicare as well as to
Medicaid and the Children’s Health
Insurance Program (CHIP). Qualified
individuals and qualified employers are
now able to purchase private health
insurance coverage through competitive
marketplaces, called an Affordable
Insurance Exchange (also called Health
Insurance MarketplaceSM,2 or
MarketplaceSM). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
MarketplaceSM. The Panel allows us to
consider a broad range of views and
information from interested audiences
in connection with this effort and to
identify opportunities to enhance the
effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education.
2 Health Insurance MarketplaceSM and
MarketplaceSM are service marks of the U.S.
Department of Health & Human Services.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
35531
II. Provisions of This Notice
Pursuant to the charter approved on
January 19, 2017, the APOE was
renewed. The APOE will advise the
Department of Health and Human
Services and CMS on developing and
implementing education programs that
support individuals enrolled in or
eligible for Medicare, Medicaid, the
CHIP, coverage through the Health
Insurance Marketplace and other CMS
programs about options for selecting
health care coverage under these and
other programs envisioned under health
care reform to ensure improved access
to quality care, including prevention
services. The scope of this FACA group
also includes advising on education of
providers and stakeholders with respect
to health care reform and certain
provisions of the HITECH Act enacted
as part of ARRA. The charter will
terminate on January 19, 2019, unless
renewed by appropriate action. The
APOE was chartered under 42 U.S.C.
217a, section 222 of the Public Health
Service Act, as amended. The APOE is
governed by provisions of Public Law
92–463, as amended (5 U.S.C. appendix
2), which sets forth standards for the
formation and use of advisory
committees.
Pursuant to the renewed charter, the
APOE will advise the Secretary of
Health and Human Services and the
CMS Administrator concerning optimal
strategies for the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in or eligible for
Medicare, Medicaid, and CHIP or health
coverage available through the Health
Insurance Marketplace and other CMS
programs.
• Enhancing the Federal
government’s effectiveness in informing
the Medicare, Medicaid, CHIP or the
Health Insurance Marketplace
consumers, issuers, providers and
stakeholders pursuant to education and
outreach programs of issues regarding
these programs, including the
appropriate use of public-private
partnerships to leverage the resources of
the private sector in educating
beneficiaries, providers, and
stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Medicare, Medicaid,
CHIP, and Health Insurance
Marketplace education programs and
other CMS programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
E:\FR\FM\31JYN1.SGM
31JYN1
35532
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including preventive services,
envisioned under the Affordable Care
Act.
The current members of the Panel are:
Kellan Baker, Associate Director, Center
for American Progress; Robert Blancato,
President, Matz, Blancato & Associates;
Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics,
Arkansas Children’s Hospital; Deborah
Britt, Executive Director of Community
& Public Relations, Piedmont Fayette
Hospital; Deena Chisolm, Associate
Professor of Pediatrics & Public Health,
The Ohio State University, Nationwide
Children’s Hospital; Josephine DeLeon,
Director, Anti-Poverty Initiatives,
Catholic Charities of California; Robert
Espinoza, Vice President of Policy,
Paraprofessional Healthcare Institute;
Louise Scherer Knight, Director, The
Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins; Roanne
Osborne-Gaskin, M.D., Senior Medical
Director, MDWise, Inc.; Cathy Phan,
Outreach and Education Coordinator,
Asian American Health Coalition DBA
HOPE Clinic; Kamilah Pickett,
Litigation Support, Independent
Contractor; Brendan Riley, Outreach
and Enrollment Coordinator, NC
Community Health Center Association;
Alvia Siddiqi, Medicaid Managed Care
Community Network (MCCN) Medical
Director, Advocate Physician Partners,
Carla Smith, Executive Vice President,
Healthcare Information and
Management Systems Society (HIMSS);
Tobin Van Ostern, Vice President and
Co-Founder, Young Invincibles
Advisors; and Paula Villescaz, Senior
Consultant, Assembly Health
Committee, California State Legislature.
sradovich on DSKBCFCHB2PROD with NOTICES
III. Copies of the Charter
The Secretary’s Charter for the APOE
is available on the CMS Web site at:
https://www.cms.gov/Regulations-andGuidance/Guidance/FACA/Downloads/
APOECharter2017.pdf or you may
obtain a copy of the charter by
submitting a request to: Thomas Dudley,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 7500
Security Boulevard, Mailstop S1 05–06,
Baltimore, MD 21244 1850 or via email
at Thomas.Dudley@cms.hhs.gov.
VerDate Sep<11>2014
17:38 Jul 28, 2017
Jkt 241001
Dated: July 21, 2017.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2017–15960 Filed 7–28–17; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–4179]
Cardiac Troponin Assays; Public
Workshop; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
workshop entitled ‘‘Cardiac Troponin
Assays.’’ The purpose of the workshop
is to discuss the development of
innovative troponin assays designed to
aid in the diagnosis of myocardial
infarction (MI) and additional clinical
uses of these assays. The workshop is
intended to enhance engagement with
stakeholders to facilitate device
development and to discuss scientific
and regulatory challenges associated
with the analytical and clinical
validation methods for troponin assay
devices. Public input and feedback
gained through this workshop may aid
in the development of science-based
approaches to aid in the efficient
development of innovative, safe and
effective, troponin diagnostic assays,
which may lead to better patient care.
DATES: The public workshop will be
held on November 28, 2017, from 8:30
a.m. to 5 p.m. Submit either electronic
or written comments on this public
workshop by November 27, 2017. See
the SUPPLEMENTARY INFORMATION section
for registration date and information.
ADDRESSES: The public workshop will
be held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Bldg. 31,
Rm. 1503 (The Great Room), Silver
Spring, MD 20993. Entrance for the
public workshop participants (non-FDA
employees) is through Building 1 where
routine security check procedures will
be performed. For parking and security
information, please refer to https://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Electronic comments must be submitted
on or before November 27, 2017. The
https://www.regulations.gov electronic
filing system will accept comments
until midnight Eastern Time at the end
of November 27, 2017. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–N–4179 for ‘‘Cardiac Troponin
Assays.’’ Received comments, those
filed in a timely manner (see
ADDRESSES) will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
E:\FR\FM\31JYN1.SGM
31JYN1
Agencies
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Pages 35530-35532]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15960]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7045-N]
Health Insurance Marketplace\SM\, Medicare, Medicaid, and
Children's Health Insurance Programs; Announcement of the Renewal of
the Charter for the Advisory Panel on Outreach and Education (APOE)
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the renewal of the charter of the
Advisory Panel on Outreach and Education APOE (the Panel) in accordance
with the Federal Advisory Committee Act. The Panel advises and makes
recommendations to the Secretary of the U.S. Department of Health and
Human Services (HHS) and the Administrator of the Centers for Medicare
& Medicaid
[[Page 35531]]
Services (CMS) on opportunities to enhance the effectiveness of
consumer education strategies concerning the Health Insurance
Marketplace\SM\, Medicare, Medicaid, and the Children's Health
Insurance Program (CHIP). Additional information about the Panel is
available on the Internet at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through
the CMS Press Office at (202) 690-6145.
FOR FURTHER INFORMATION CONTACT: Thomas Dudley, (410) 786-1442.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. appendix 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (42
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42
U.S.C. 217a).
On January 21, 1999, the Secretary of the U.S. Department of Health
and Human Services (HHS) (the Secretary) signed the charter
establishing the Citizen's Advisory Panel on Medicare Education \1\
(the predecessor to the APOE) to advise and make recommendations to the
Secretary and the Administrator of the Centers for Medicare & Medicaid
Services (CMS) on the effective implementation of national Medicare
education programs, including with respect to the Medicare+Choice (M+C)
program added by the Balanced Budget Act of 1997 (Pub. L. 105-33). (For
more detailed information, see the February 17, 1999 Federal Register
(64 FR 7899)).
---------------------------------------------------------------------------
\1\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173)
expanded the existing health plan options and benefits available under
the M+C program and renamed it the Medicare Advantage (MA) program. CMS
has substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options available and
better tools to evaluate these options. Successful MA program
implementation required CMS to consider views and policy input from a
variety of private sector constituents and to develop a broad range of
public-private partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
CMS has substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available and to develop better tools to evaluate these plans and
benefits.
The Affordable Care Act (Patient Protection and Affordable Care
Act, Public Law 111-148, and Health Care and Education Reconciliation
Act of 2010, Public Law 111-152) expanded the availability of options
for health care coverage and enacted a number of changes to Medicare as
well as to Medicaid and the Children's Health Insurance Program (CHIP).
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through competitive marketplaces,
called an Affordable Insurance Exchange (also called Health Insurance
Marketplace\SM\,\2\ or Marketplace\SM\). In order to effectively
implement and administer these changes, we must provide information to
consumers, providers, and other stakeholders through education and
outreach programs regarding how existing programs will change and the
expanded range of health coverage options available, including private
health insurance coverage through the Marketplace\SM\. The Panel allows
us to consider a broad range of views and information from interested
audiences in connection with this effort and to identify opportunities
to enhance the effectiveness of education strategies concerning the
Affordable Care Act.
---------------------------------------------------------------------------
\2\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are
service marks of the U.S. Department of Health & Human Services.
---------------------------------------------------------------------------
The scope of this panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education.
II. Provisions of This Notice
Pursuant to the charter approved on January 19, 2017, the APOE was
renewed. The APOE will advise the Department of Health and Human
Services and CMS on developing and implementing education programs that
support individuals enrolled in or eligible for Medicare, Medicaid, the
CHIP, coverage through the Health Insurance Marketplace and other CMS
programs about options for selecting health care coverage under these
and other programs envisioned under health care reform to ensure
improved access to quality care, including prevention services. The
scope of this FACA group also includes advising on education of
providers and stakeholders with respect to health care reform and
certain provisions of the HITECH Act enacted as part of ARRA. The
charter will terminate on January 19, 2019, unless renewed by
appropriate action. The APOE was chartered under 42 U.S.C. 217a,
section 222 of the Public Health Service Act, as amended. The APOE is
governed by provisions of Public Law 92-463, as amended (5 U.S.C.
appendix 2), which sets forth standards for the formation and use of
advisory committees.
Pursuant to the renewed charter, the APOE will advise the Secretary
of Health and Human Services and the CMS Administrator concerning
optimal strategies for the following:
Developing and implementing education and outreach
programs for individuals enrolled in or eligible for Medicare,
Medicaid, and CHIP or health coverage available through the Health
Insurance Marketplace and other CMS programs.
Enhancing the Federal government's effectiveness in
informing the Medicare, Medicaid, CHIP or the Health Insurance
Marketplace consumers, issuers, providers and stakeholders pursuant to
education and outreach programs of issues regarding these programs,
including the appropriate use of public-private partnerships to
leverage the resources of the private sector in educating
beneficiaries, providers, and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Medicare, Medicaid, CHIP, and Health Insurance Marketplace education
programs and other CMS programs as designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
[[Page 35532]]
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
preventive services, envisioned under the Affordable Care Act.
The current members of the Panel are: Kellan Baker, Associate
Director, Center for American Progress; Robert Blancato, President,
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic
Surgery, Department of Orthopaedics, Arkansas Children's Hospital;
Deborah Britt, Executive Director of Community & Public Relations,
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of
Pediatrics & Public Health, The Ohio State University, Nationwide
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty
Initiatives, Catholic Charities of California; Robert Espinoza, Vice
President of Policy, Paraprofessional Healthcare Institute; Louise
Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director,
MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian
American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation
Support, Independent Contractor; Brendan Riley, Outreach and Enrollment
Coordinator, NC Community Health Center Association; Alvia Siddiqi,
Medicaid Managed Care Community Network (MCCN) Medical Director,
Advocate Physician Partners, Carla Smith, Executive Vice President,
Healthcare Information and Management Systems Society (HIMSS); Tobin
Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors;
and Paula Villescaz, Senior Consultant, Assembly Health Committee,
California State Legislature.
III. Copies of the Charter
The Secretary's Charter for the APOE is available on the CMS Web
site at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/Downloads/APOECharter2017.pdf or you may obtain a copy of the charter
by submitting a request to: Thomas Dudley, Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 7500 Security Boulevard, Mailstop S1 05-06, Baltimore, MD
21244 1850 or via email at Thomas.Dudley@cms.hhs.gov.
Dated: July 21, 2017.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2017-15960 Filed 7-28-17; 8:45 am]
BILLING CODE 4120-01-P